Clinical trial
The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers
NCT04960657 is registered in ClinicalTrials.gov with Danish Headache Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers
- Lead sponsor
- Danish Headache Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 20, 2020
- Completion date
- March 19, 2021
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.